Sign in or register to see full information and data.

Studies / CAVD 405


Study information

Grant Affiliation:Third party request
Strategy:Combo: Protein & vector vaccines
Study Type:Pre-Clinical NHP
Species:Rhesus macaque
Stage:Assays Completed
Study Start Date:2013-01-04
Study Made Public:2015-09-17


NHP Study P162 - a recapitulation of RV144 in NHP, with alternate adjuvants and boosting with differing protein constructs


CAVD 405 (NHP Study P162) is a non-human primate challenge study of ALVAC/protein prime/boost regimens.


Alum MF59 SIVmac251 None gD-766gp120 gD-CG7Vgp120 ALVAC parental ALVAC-SIV 766 Gag-pro-SIV 766gp120-TM ALVAC-SIV K6W SC 766 SC CG7V SIV mac251 protein

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.